Register for free to listen to this article
Listen with Speechify
0:00
2:00
TORONTO—A chemistry professor and graduate student at the University of Toronto have teamed up for research that may not only allow scientists to generate new kinds of proteins, but could also eventually lead to practical applications such as simplifying drug development.
 
Professor Ronald Kluger and doctoral candidate Svetlana Tzvetkova led a team that modified the steps involved in creating proteins.
 
In a statement, Kluger says he became interested in the possibility of manipulating proteins after learning about efforts to produce "designer amino acids."
 
"I was intrigued by the possibility that someone could actually attempt to make proteins with amino acids that aren't specified in the genetic code at all," says Kluger.
 
In nature, there are 20 different amino acids that can link together to make proteins. Protein creation begins with DNA, which sends out genetic instructions via an RNA message (mRNA) to the ribosomes in human cells. tRNA collect the amino acids and bring them to the ribosomes. The tRNA then aligns with mRNA so the amino acids can join to form proteins. The catch is that an amino acid has to be activated by a specific enzyme before the tRNA can scoop it up.
 
Kluger and another student, Lisa Cameron, found that they could mimic the critical action of this enzyme when they combined common inorganic chemicals called lanthanum salts with a chemically activated amino acid. Tzvetkova showed the chemical mimic will allow an amino acid to attach to the complex tRNA molecule in just the right place.
 
The results of the research were e-published in the Dec. 4 issue of the Journal of the American Chemical Society. The research could be developed to allow tRNA to collect new "unnatural" amino acids, which Kluger points out could "give anyone the ability to create totally new materials that have nothing to do with the genetically defined functions of proteins."
 
According to Kluger, scientists have been trying this type of modification for years, using methods involving a number of difficult steps.
 
"They started to mutate the enzymes instead of doing a chemical alteration," says Kluger, who explains the elegance of his method is that it changes how amino acids are added to tRNA "in one step, just the way nature does it."

Related Topics

Loading Next Article...
Loading Next Article...
Subscribe to Newsletter

Subscribe to our eNewsletters

Stay connected with all of the latest from Drug Discovery News.

Subscribe

Sponsored

A black mosquito is shown on pink human skin against a blurred green backdrop.

Discovering deeper insights into malaria research

Malaria continues to drive urgent research worldwide, with new therapies and tools emerging to combat the parasite’s complex lifecycle and global burden.
Three burgundy round and linear conformations of oligonucleotides are shown against a black background.

Accelerating RNA therapeutic testing with liver microphysiological platforms

Researchers can now study oligonucleotide delivery and efficacy in a system that models a real human liver.
A 3D-rendered illustration of a eukaryotic cell highlighting organelles such as the nucleus, endoplasmic reticulum, mitochondria, and cytoskeletal structures in pink and purple tones.

Shining light on the subcellular proteome

Discover how innovative proteomics tools help researchers peer into once inaccessible organelles, allowing for new targets for drug discovery and development.
Drug Discovery News March 2025 Issue
Latest IssueVolume 21 • Issue 1 • March 2025

March 2025

March 2025 Issue

Explore this issue